Rigel PharmaceuticalsRIGL
13F holders, Q3 2024 (September 30)4holders −6
1new positions
6sold out
$16.16avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, down 6 from Q2 2024. 1 opened new positions and 6 sold out. The largest holders were Farther Finance Advisors, LLC ($11K), EverSource Wealth Advisors, LLC ($1K) and Hexagon Capital Partners LLC ($32).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 6 | $90K |
All 13F filers, Q2 2024 → Q3 2024: 667 shares bought and 12,692 shares sold, net −12,025 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Farther Finance Advisors, LLC | 0.00% | New | 667 | $11K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 63 | $1K |
| Hexagon Capital Partners LLC | 0.00% | No change | 2 | $32 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.